Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Pegylated recombinant factor VIIa

EU orphan designation number: EU/3/08/552
Active ingredient: Pegylated recombinant factor VIIa
Indication: Treatment of haemophilia B
Sponsor: Novo Nordisk A/S
Novo Allé, DK-2880 Bagsvaerd, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/06/2008 Orphan designation EMEA/OD/008/08 (2008)2539 of 03/06/2008
08/09/2014 Removal of orphan designation from Community Register